BioNTech
BNTX
335 hedge funds and large institutions have $10B invested in BioNTech in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 34 closing their positions.
159% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 34
28% more capital invested
Capital invested by funds: $7.83B → $10B (+$2.17B)
18% more funds holding
Funds holding: 283 → 335 (+52)
0.73% more ownership
Funds ownership: 14.65% → 15.39% (+0.73%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
9% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 102
36% less call options, than puts
Call options by funds: $1.48B | Put options by funds: $2.32B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$1.21B |
| 2 |
PG
Pendal Group
Sydney,
Australia
|
+$463M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$85.3M |
| 4 |
D.E. Shaw & Co
New York
|
+$84.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$75.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gates Foundation
Seattle,
Washington
|
-$283M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$276M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$157M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$130M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$116M |
BNTX Hedge Fund Activity: Q3 2021 in Review
335 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2021, worth a combined $10B — up 28% from $7.83B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new BNTX positions and 34 closed out — a net gain of 54 holders — while 93 added to existing stakes and 102 trimmed.
The largest buyer was Jennison Associates, adding an estimated $1.21B. The largest seller was Gates Foundation, cutting an estimated $283M.
- 335 institutional investors held BioNTech (BNTX) as of Q3 2021, up from 283 in Q2 2021.
- Funds reported $10B of BioNTech stock for Q3 2021, up 28% quarter-over-quarter.
- 88 funds opened new BioNTech positions in Q3 2021 and 34 closed out, a net change of +54 holders.
- The largest BioNTech buyer in Q3 2021 was Jennison Associates, an estimated $1.21B added.
- The largest BioNTech seller in Q3 2021 was Gates Foundation, an estimated $283M sold.
Based on aggregated 13F filings for Q3 2021.